MESENCHYMAL STEM CELLS AS A THERAPEUTIC STRATEGY FOR MULTIPLE SCLEROSIS: ISSUES AND PERSPECTIVES
The ability of mesenchymal stem cells (MSC) to influence the regulatory/suppressive effect in the autoimmune process and promote remyelination allows to consider them a new method of multiple sclerosis (MS) therapy, by means of modifying the disease activity. Genetic stability, proliferative potenti...
Main Authors: | M. M. Zafranskaya, D. B. Nizhegorodova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2017-01-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/1392 |
Similar Items
-
MECHANISMS OF ANTI-PROLIFERATIVE EFFECT PRODUCED BY MESENCHYMAL STEM CELLS IN PATIENTS WITH MULTIPLE SCLEROSIS
by: M. M. Zafranskaya, et al.
Published: (2014-07-01) -
MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis
by: Antonio Uccelli, et al.
Published: (2019-05-01) -
Mesenchymal stem cell therapy: A review of clinical trials for multiple sclerosis
by: Asma Alanazi, et al.
Published: (2022-12-01) -
Mesenchymal stem cells in dogs with demyelinating leukoencephalitis as an experimental model of multiple sclerosis
by: Luane Lopes Pinheiro, et al.
Published: (2019-06-01) -
Long-Term Clinical and Immunological Effects of Repeated Mesenchymal Stem Cell Injections in Patients With Progressive Forms of Multiple Sclerosis
by: Panayiota Petrou, et al.
Published: (2021-05-01)